An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy
Clinical trial NCT01568190 · COMPLETED
Trial details
- NCT number
- NCT01568190
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-07-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.